Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion

被引:108
|
作者
Wimmel, A
Glitz, D
Kraus, A
Roeder, J
Schuermann, M
机构
[1] Klinikum Univ Marburg, Klin Innere Med Sp Hamatol Onkol Immunol, D-35033 Marburg, Germany
[2] Aventis Behring GMBH, D-35041 Marburg, Germany
关键词
Axl receptor tyrosine kinase; Gas6; lung cancer; cell adhesion;
D O I
10.1016/S0959-8049(01)00271-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Axl is a receptor tyrosine kinase (RTK) with oncogenic potential and transforming activity, Since Axl bears structural similarities to cell adhesion molecules such as neural cell adhesion molecule (NCAM) (FNIII domains), it is thought that Axl might play a role in adhesion. In this study, we have analysed the expression of the Axl protein and its ligand, Gas6. in human lung cancer cell lines of different histological origin. Axl expression occurred in approximately 60% of non-small Cell lung cancer (NSCLC) cell lines, which grow adherently, and in normal bronchial epithelial cells (NHBE). but not ill cell lines of small cell lung cancer origin (SCLC), which grow in suspension. A number of SCLC sublines, which could be selected spontaneously or after oneogene transfection for adherent growth, all expressed Axl protein. Overexpression of Axl per se, however. did not induce ally change in the adhesion phenotype. All Axl-expressing cell lines demonstrated a membrane-bound 140 kD form, as well as a soluble 85 kD form, detectable in supernatant, of Axl-RTK. Expression or the Axl ligand Gas6 was detected in approximately 80% of all cell lines investigated. We conclude from these data that loss of Axl expression is a feature or SCLC tumour cells. Axl expression appears to be a consequence of cellular adhesion and possibly influences differentiation in human lung cancers. (C) 2001 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2264 / 2274
页数:11
相关论文
共 50 条
  • [31] Expression of estrogen receptors α and β in human lung tissue and cell lines
    Mollerup, S
    Jorgensen, K
    Berge, G
    Haugen, A
    LUNG CANCER, 2002, 37 (02) : 153 - 159
  • [32] Combined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancer
    Wairagu, Peninah M.
    Park, Kwang Hwa
    Kim, Jihye
    Choi, Jong-Whan
    Kim, Hyun-Won
    Yeh, Byung-Il
    Jung, Soon-Hee
    Yong, Suk-Joong
    Jeong, Yangsik
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 447 (03) : 490 - 495
  • [33] Differential expression of inflammasomes in lung cancer cell lines and tissues
    Kong, Hui
    Wang, Yanli
    Zeng, Xiaoning
    Wang, Zailiang
    Wang, Hong
    Xie, Weiping
    TUMOR BIOLOGY, 2015, 36 (10) : 7501 - 7513
  • [34] Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
    Liu, Yi-Nan
    Tsai, Meng-Feng
    Wu, Shang-Gin
    Chang, Tzu-Hua
    Tsai, Tzu-Hsiu
    Gow, Chien-Hung
    Chang, Yih-Leong
    Shih, Jin-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (06) : 1609 - 1624
  • [35] Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
    Rath, Barbara
    Plangger, Adelina
    Hamilton, Gerhard
    CANCER DRUG RESISTANCE, 2020, 3 (02) : 171 - 178
  • [36] In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways
    Alison C Kraus
    Ines Ferber
    Sven-Oliver Bachmann
    Hannah Specht
    Anja Wimmel
    Markus W Gross
    Juergen Schlegel
    Guntram Suske
    Marcus Schuermann
    Oncogene, 2002, 21 : 8683 - 8695
  • [37] In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways
    Kraus, AC
    Ferber, I
    Bachmann, SO
    Specht, H
    Wimmel, A
    Gross, MW
    Schlegel, J
    Suske, G
    Schuermann, M
    ONCOGENE, 2002, 21 (57) : 8683 - 8695
  • [38] Antiproliferative action of metformin in human lung cancer cell lines
    Ashinuma, Hironori
    Takiguchi, Yuichi
    Kitazono, Satoru
    Kitazono-Saitoh, Miyako
    Kitamura, Atsushi
    Chiba, Tetsuhiro
    Tada, Yuji
    Kurosu, Katsushi
    Sakaida, Emiko
    Sekine, Ikuo
    Tanabe, Nobuhiro
    Iwama, Atsushi
    Yokosuka, Osamu
    Tatsumi, Koichiro
    ONCOLOGY REPORTS, 2012, 28 (01) : 8 - 14
  • [39] The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines
    Shen, Lan
    Li, Ziming
    Shen, Shengping
    Niu, Xiaomin
    Yu, Yongfeng
    Li, Zonghai
    Liao, Meilin
    Chen, Zhiwei
    Lu, Shun
    LUNG CANCER, 2012, 78 (03) : 193 - 200
  • [40] Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines
    Chen, Qing-Yong
    Jiao, De-Min
    Yao, Qing-Hua
    Yan, Jie
    Song, Jia
    Chen, Fang-Yuan
    Lu, Guo-Hua
    Zhou, Jan-Ying
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1561 - 1568